Molecular Shape Analysis-Guided Virtual Screening Platform for Adenosine Kinase Inhibitors

Area of Science:

• Computational chemistry
• Drug discovery
• Molecular modeling

Background:

• Virtual screening (VS) is crucial for identifying drug candidates.
• Adenosine kinase (AK) is a therapeutic target, but effective inhibitors are needed.
• Accurate prediction of molecular interactions is challenging in VS.

Purpose of the Study:

• To introduce a novel hierarchical VS strategy using molecular shape descriptors.
• To identify potent inhibitors of adenosine kinase (AK).
• To establish guidelines for selecting successful compounds against AK.

Main Methods:

• Structure-based pharmacophore and docking-guided VS protocol.
• Application of molecular shape analysis (MSA) descriptors for hierarchical filtering.
• Development of recursive models based on MSA descriptors and docking scores.

Main Results:

• Successfully classified active and inactive molecules against AK based on shape.
• Enabled selection of appropriate ligand conformations within the binding site.
• Demonstrated the importance of spatial requirements for AK inhibitors.

Conclusions:

• The proposed hierarchical VS approach enhances the identification of AK inhibitors.
• Molecular shape analysis is a valuable tool for prioritizing compounds in VS.
• This strategy provides a systematic framework for understanding inhibitor spatial limitations.